SCHEMBL6740439

SCHEMBL6740439

N#Cc1ccc(-c2nc(NCc3ccccc3Cl)nc(-c3ccc(C#N)cc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.49
PDE5A O76074 1/20 0.49
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 2/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 6/20 0.44
GAA P10253 3/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
TP53 P04637 1/20 0.42
ABCB1 P08183 5/20 0.42
ABCG2 Q9UNQ0 5/20 0.42
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743401 0.80 ABCG2 (0.61) PDE5AALDH1A1HSD17B10MAPK1HTT
SCHEMBL6739817 0.77 HDAC3 (0.49) PDE5AHPGDHSD17B10MAPTLMNA
SCHEMBL31194517 0.74 PDE5A (0.43) VNN1PDE5AALDH1A1KDM4EHPGD
SCHEMBL31663591 0.72 ABCG2 (0.62) HSD17B10TSHRABCB1ABCG2ABCC1
SCHEMBL2479265 0.72 MMP3 (0.52) ALDH1A1GAATSHRABCB1ABCG2
SCHEMBL31612415 0.71 ABCG2 (0.54) KDM4EHPGDGAALMNATSHR
SCHEMBL22073476 0.71 ABCG2 (0.54) KDM4EHPGDGAALMNATSHR
SCHEMBL21849416 0.71 ABCG2 (0.54) ALDH1A1HPGDTSHRABCB1ABCG2
SCHEMBL29450769 0.71 ABCG2 (0.54) ALDH1A1HPGDTSHRABCB1ABCG2
SCHEMBL6737053 0.71 HPGD (0.48) ALDH1A1HPGDMAPK1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082627-A1 Certain aromatic monocycles as kinase modulators CGI PHARMACEUTICALS, INC. 2004-04-29 US disclosed
WO-2004000820-A2 CERTAIN AROMATIC MONOCYCLES AS KINASE MODULATORS CELLULAR GENOMICS, INC. (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082627-A1 Certain aromatic monocycles as kinase modulators MAP3K20, MAP3K1, MAP3K19 VNN1 4584/4885PDE5A 2755/4885ALDH1A1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.